Increasing incidence of diseases such as cancer, Alzheimer, and cardiovascular diseases are expected to drive growth of the PET-CT Scanner Device Market.
Positron emission tomography-computed tomography (PET-CT) is a nuclear medicine procedure used to evaluate how organ systems of the body function and to identify and distinguish between both primary and metastatic cancer, heart diseases, and brain disorders. Positron emission tomography (PET) uses small amounts of radioactive materials called radiotracers, a special camera, and a computer to help evaluate organ and tissue functions. This type of medical procedure is highly sensitive imaging and detects diseases at early stage. The equipment is used for diagnose various types of cancers, such as colorectal cancers and lymphomas, as well as some neurological and cardiac conditions.
The global PET-CT scanner device market is segmented on the basis of end user, applications, and region. On the basis of end user, the global market is segmented into hospitals, diagnostic centers, research institutes
The global PET-CT scanner device market is estimated to account for majority revenue share in 2018, and is expected to continue contributing the highest revenue share over the forecast period (2018 – 2027). The hospitals segment is projected to register highest CAGR in the global market over the forecast period.
On the basis of applications, the global market is segmented into cardiology, oncology, neurology.
The oncology segment is estimated to account for highest share in terms of revenue, and is expected to continue dominating in the global market over the forecast period. The cardiology segment is projected to register highest growth rate between 2018 and 2027.
On the basis of region, the global PET-CT scanner device market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in Asia Pacific is estimated to account for highest share in terms of revenue, and is expected to maintain its dominance over the forecast period. The Asia Pacific market is expected to witness highest growth in terms of revenue during the forecast period. The market in North America is expected to account for significant share in the global market.
Key players operating in the global PET-CT scanner device market include
- GE Healthcare Inc.
- Hitachi, Ltd.
- Mediso Ltd.
- Koninklijke Philips N.V.
- PerkinElmer, Inc.
- Positron Corporation
- Siemens AG